Wave Life Sciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $8,699 | $9,175 | $83,748 | $-7,676 |
Gross Profit | 8,699 | 9,175 | 83,748 | -7,676 |
EBITDA | -50,563 | -47,640 | 25,123 | -61,757 |
EBIT | -52,759 | -49,804 | 22,967 | -63,915 |
Net Income | -50,469 | -46,878 | 29,253 | -61,780 |
Net Change In Cash | 8,699 | 9,175 | 83,748 | -7,676 |
Free Cash Flow | -46,318 | -63,204 | -43,734 | -46,861 |
Cash | 208,481 | 243,075 | 302,078 | 310,948 |
Basic Shares | 163,987 | 162,527 | 172,290 | 132,563 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $108,302 | $113,305 | $3,649 | $40,964 |
Gross Profit | 108,302 | 104,099 | 3,649 | -80,911 |
EBITDA | -101,740 | -58,790 | -152,606 | -117,181 |
EBIT | -110,403 | -67,996 | -162,720 | -127,016 |
Net Income | -97,008 | -57,513 | -161,823 | -122,245 |
Net Change In Cash | 108,302 | 113,305 | 3,649 | 40,964 |
Cost of Revenue | -61,848 | -33,725 | ||
Free Cash Flow | -151,964 | -20,546 | -129,142 | -89,553 |
Cash | 302,078 | 200,351 | 88,497 | 150,564 |
Basic Shares | 138,277 | 106,097 | 78,855 | 51,825 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.31 |
2025-03-31 | -$0.29 |
2024-12-31 | $0.17 |
